ORG Wealth Partners’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$241K Buy
672
+660
+5,500% +$202K 0.04% 232
2026
Q1
$3.01K Sell
12
-58
-83% -$14.4K ﹤0.01% 573
2025
Q4
$19.3K Sell
70
-8
-10% -$2.19K ﹤0.01% 406
2025
Q3
$20.5K Sell
78
-110
-59% -$26.7K ﹤0.01% 394
2025
Q2
$41.5K Sell
188
-7
-4% -$1.5K 0.01% 342
2025
Q1
$43.2K Sell
195
-391
-67% -$108K 0.01% 363
2024
Q4
$192K Buy
586
+28
+5% +$8.81K 0.06% 129
2024
Q3
$167K Buy
+558
New +$171K 0.06% 136

Other funds holding WST

ORG Wealth Partners's WST Position: Q2 2026 in Review

ORG Wealth Partners increased its West Pharmaceutical (WST) stake by 5,500% in Q2 2026, buying an estimated $202K and bringing the position to 672 shares worth $241K. The position accounts for 0.04% of the portfolio, ranked #232.

ORG Wealth Partners first reported a position in WST in Q3 2024 and has held it in 8 quarters since. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • ORG Wealth Partners held 672 shares of West Pharmaceutical worth $241K as of Q2 2026.
  • ORG Wealth Partners bought 660 West Pharmaceutical shares in Q2 2026, an estimated $202K.
  • West Pharmaceutical made up 0.04% of ORG Wealth Partners's portfolio in Q2 2026, its #232 holding.
  • ORG Wealth Partners first reported a position in West Pharmaceutical in Q3 2024 and has held it in 8 quarters since.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on ORG Wealth Partners's 13F filing for Q2 2026, filed 27 Jul 2026.